| Literature DB >> 30651401 |
Steffen L Jørgensen1, Marc Stegger2,3, Eglé Kudirkiene4, Berit Lilje2, Louise L Poulsen4, Troels Ronco5, Teresa Pires Dos Santos4, Kristoffer Kiil2, Magne Bisgaard6, Karl Pedersen5, Lisa K Nolan7, Lance B Price3, Rikke H Olsen4, Paal S Andersen4,2, Henrik Christensen4.
Abstract
Avian-pathogenic Escherichia coli (APEC) is a subgroup of extraintestinal pathogenic E. coli (ExPEC) presumed to be zoonotic and to represent an external reservoir for extraintestinal infections in humans, including uropathogenic E. coli (UPEC) causing urinary tract infections. Comparative genomics has previously been applied to investigate whether APEC and human ExPEC are distinct entities. Even so, whole-genome-based studies are limited, and large-scale comparisons focused on single sequence types (STs) are not available yet. In this study, comparative genomic analysis was performed on 323 APEC and human ExPEC genomes belonging to sequence type 95 (ST95) to investigate whether APEC and human ExPEC are distinct entities. Our study showed that APEC of ST95 did not constitute a unique ExPEC branch and was genetically diverse. A large genetic overlap between APEC and certain human ExPEC was observed, with APEC located on multiple branches together with closely related human ExPEC, including nearly identical APEC and human ExPEC. These results illustrate that certain ExPEC clones may indeed have the potential to cause infection in both poultry and humans. Previously described ExPEC-associated genes were found to be encoded on ColV plasmids. These virulence-associated plasmids seem to be crucial for ExPEC strains to cause avian colibacillosis and are strongly associated with strains of the mixed APEC/human ExPEC clusters. The phylogenetic analysis revealed two distinct branches consisting of exclusively closely related human ExPEC which did not carry the virulence-associated plasmids, emphasizing a lower avian virulence potential of human ExPEC in relation to an avian host.IMPORTANCE APEC causes a range of infections in poultry, collectively called colibacillosis, and is the leading cause of mortality and is associated with major economic significance in the poultry industry. A growing number of studies have suggested APEC as an external reservoir of human ExPEC, including UPEC, which is a reservoir. ExPEC belonging to ST95 is considered one of the most important pathogens in both poultry and humans. This study is the first in-depth whole-genome-based comparison of ST95 E. coli which investigates both the core genomes as well as the accessory genomes of avian and human ExPEC. We demonstrated that multiple lineages of ExPEC belonging to ST95 exist, of which the majority may cause infection in humans, while only part of the ST95 cluster seem to be avian pathogenic. These findings further support the idea that urinary tract infections may be a zoonotic infection.Entities:
Keywords: E. coli; genomics; pathogenicity; sequencing; zoonosis
Mesh:
Year: 2019 PMID: 30651401 PMCID: PMC6336079 DOI: 10.1128/mSphere.00333-18
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1Rooted phylogenetic trees of the core genome (A) and accessory genome (B) of 323 genomes in the study. APEC genomes are marked with red dots on the branch ends. Subclades consisting exclusively of human ExPEC were identified in the core and accessory phylogenies and indicated by colored branches. The human ExPEC/HExPEC-1 subclade (blue) was distinct in both the core and accessory genome phylogenies. The HExPEC-2 subclade (green) was identified in the accessory-genome-derived tree, while a less distinct clustering was identified in the core genome phylogeny. Branches with mixes of both APEC and human ExPEC were designated A/E-PEC branches.
Gene presence/absence profile for the discriminating the human ExPEC clusters HExPEC-1 and HExPEC-2 apart from the mixed A/E-PEC cluster
| Prevalence (%) | Gene presence/absence profile | Gene | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A/E-PEC | HExPEC-1 | HExPEC-2 | gene3477 | gene8134 | |||||||||||
| 98 | 0 | 98 | − | − | + | ||||||||||
| 0 | 98 | 0 | + | + | − | ||||||||||
| 0 | 96 | 6 | + | − | − | − | − | − | − | ||||||
| 92 | 2 | 2 | − | ||||||||||||
| 0 | 0 | 94 | − | − | − | − | − | − | − | ||||||
| 0 | 0 | 98 | |||||||||||||
Open or blank gene cells were not relevant for the gene profile.
Prevalence of the investigated ExPEC-associated genes
| Category and gene | Description | Prevalence (%) | GenBank accession no. | ||||
|---|---|---|---|---|---|---|---|
| APEC | ExPEC | A/E-PEC | HExPEC-1 | HExPEC-2 | |||
| A/E-PEC-associated genes | |||||||
| | Aerobactin synthesis | 96.9 | 35.4 | 85.4 | 14.5 | 4.2 | |
| | Aerobactin synthesis | 96.9 | 35.4 | 86.2 | 13.8 | 4.2 | |
| | Iron transport | 96.9 | 35.1 | 84.6 | 14.5 | 4.2 | |
| | Colicin V | 96.9 | 33.0 | 83.1 | 13.1 | 0.0 | |
| | ABC transport system | 96.9 | 30.6 | 77.7 | 13.1 | 0.0 | |
| | Hemolysin | 93.8 | 34.4 | 85.4 | 13.1 | 0.0 | |
| | Outer membrane protease | 93.8 | 34.0 | 84.6 | 13.1 | 0.0 | |
| | Colicin V | 87.5 | 33.3 | 81.5 | 13.1 | 0.0 | |
| | Colicin V | 84.4 | 32.3 | 78.5 | 13.1 | 0.0 | |
| | Colicin V immunity | 84.4 | 33.3 | 80.8 | 13.1 | 0.0 | |
| HExPEC-1- and A/E-PEC- | |||||||
| | Invasion determinant protein | 71.9 | 75.6 | 84.6 | 91.7 | 0.0 | |
| | P fimbria | 71.9 | 75.3 | 83.8 | 91.7 | 0.0 | |
| | Siderphore receptor | 71.9 | 74.9 | 83.1 | 91.7 | 0.0 | |
| | P fimbria adhesin variant | 71.9 | 74.9 | 83.8 | 91.0 | 0.0 | |
| | P fimbria shaft | 68.8 | 74.6 | 81.5 | 91.7 | 0.0 | |
| HExPEC-2-associated genes | |||||||
| | Brain epithelium invasion | 40.6 | 21.3 | 20.0 | 0.7 | 100 | |
| | S fimbria adhesin | 28.1 | 19.6 | 13.8 | 0.7 | 97.9 | |
| | S fimbria | 28.1 | 18.6 | 11.5 | 0.7 | 97.9 | |
| | Cytotoxic necrotizing factor | 0.0 | 17.2 | 3.1 | 0.7 | 93.8 | |
| | P fimbria adhesin variant | 0.0 | 15.8 | 0.8 | 0.0 | 93.8 | |
| HExPEC-2- and A/E-PEC- | |||||||
| | Siderophore | 96.9 | 49.1 | 83.1 | 13.1 | 97.9 | |
| Highly frequent (genes present | |||||||
| | Curli | 100 | 100 | 100 | 100 | 100 | |
| | Siderophore | 100 | 100 | 100 | 100 | 100 | |
| | Serum resistance | 100 | 100 | 100 | 100 | 100 | |
| | Serum survival | 100 | 100 | 100 | 100 | 100 | |
| | Iron uptake | 100 | 99.7 | 100 | 99.3 | 100 | |
| | Type 1 fimbria adhesin | 100 | 99.7 | 100 | 99.3 | 100 | |
| | Uropathogenic-specific protein (bacteriocin) | 100 | 99.3 | 99.2 | 99.3 | 100 | |
| | Yersiniabactin | 100 | 98.6 | 98.5 | 98.6 | 100 | |
| | Group 2 capsule kpsM variant | 100 | 99.7 | 99.2 | 100 | 100 | |
| | Pathogenicity island | 81.3 | 98.3 | 91.5 | 100 | 100 | |
| | P fimbria usher | 71.9 | 91.1 | 84.6 | 91.0 | 95.8 | |
| | P fimbria subunit | 71.9 | 91.4 | 85.4 | 91.7 | 93.8 | |
| | Vacuolating autotransporter toxin | 59.4 | 88.0 | 80.0 | 96.6 | 64.6 | |
| | Serum resistance | 96.9 | 77.3 | 74.6 | 88.3 | 64.6 | |
| | Iron transport | 53.1 | 78.0 | 54.6 | 88.3 | 93.8 | |
| Genes of variable presence | |||||||
| | Serum resistance | 43.8 | 57.4 | 50.0 | 66.9 | 39.6 | |
| | Iron ABC transport system | 31.3 | 11.7 | 10.8 | 9.7 | 33.3 | |
| | Colicin M | 34.4 | 2.4 | 13.1 | 0.7 | 0.0 | |
| | Colicin B immunity | 31.3 | 2.7 | 13.1 | 0.7 | 0.0 | |
| | Cytolethal distending toxin B | 0.0 | 5.8 | 12.3 | 0.0 | 2.1 | |
| Low frequency (genes identified in <5% of all investigated genomes) | |||||||
| | EAST1 toxin | 12.5 | 1.0 | 4.6 | 0.7 | 0.0 | |
| | Hemagglutinin | 12.5 | 0.0 | 3.1 | 0.0 | 0.0 | |
| | Nonfimbrial Iha adhesin | 0.0 | 0.3 | 0.0 | 0.7 | 0.0 | |
| | F1C fimbria | 0.0 | 0.3 | 0.8 | 0.0 | 0.0 | |
| | Nonfimbrial adhesin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Flagellin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | α-Hemolysin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | P fimbria adhesin variant | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Bundle-forming pilus | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Blood group M adhesin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | G-fimbriae | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Lipopolysaccharide synthesis | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Stg fimbria | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| | Shiga toxin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
The category is the gene location or gene frequency class. Genes localized on plasmid are indicated by superscript 1, genes localized on chromosome are indicated by superscript 2, and genes carried on phage are indicated by superscript 3.
FIG 2Diagram of ExPEC-associated gene distribution in the three groups; the two human ExPEC clusters HExPEC-1 and HExPEC-2 and the mixed avian/human ExPEC A/E-PEC cluster. Genes associated with the A/E-PEC are located in the gray box. HExPEC-1-associated genes are located in the yellow box. HExPEC-2- associated genes are located in the orange box.
Prevalence antibiotic classes of the different ExPEC subtypes
| Antibiotic | Prevalence (%) | |||||
|---|---|---|---|---|---|---|
| Total | APEC | Human | A/E-PEC | HExPEC-1 | HExPEC-2 | |
| Beta-lactams | 18.3 | 6.3 | 19.6 | 14.6 | 17.9 | 29.2 |
| Sulfonamides | 16.1 | 12.5 | 16.5 | 20.0 | 9.0 | 27.1 |
| Trimethoprims | 8.7 | 3.1 | 9.3 | 9.2 | 4.8 | 18.8 |
| Aminoglycosides | 7.4 | 9.4 | 7.2 | 11.5 | 3.4 | 8.3 |
| Tetracyclines | 4.6 | 3.1 | 4.8 | 3.1 | 3.4 | 12.5 |
| Macrolides | 1.2 | 0.0 | 1.4 | 0.8 | 1.4 | 2.1 |
| Quinolones | 0.3 | 0.0 | 0.3 | 0.8 | 0.0 | 0.0 |
| Multiresistance | 11.0 | 6.3 | 11.0 | 10.0 | 6.9 | 22.9 |